Inflammation-associated gut microbiome in postacute sequelae of SARS-CoV-2 points towards new therapeutic targets
Gut
.
2024 Jan 5;73(2):376-378.
doi: 10.1136/gutjnl-2022-328757.
Authors
Valdirene Leao Carneiro
1
,
Katherine M Littlefield
2
,
Renee Watson
2
,
Brent E Palmer
#
2
,
Catherine Lozupone
#
3
Affiliations
1
Department of Life Sciences, University of Bahia State, Salvador, Brazil.
2
Department of Medicine, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USA.
3
Department of Biomedical Informatics, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USA
[email protected]
.
#
Contributed equally.
PMID:
36717218
PMCID:
PMC10850647
DOI:
10.1136/gutjnl-2022-328757
No abstract available
Keywords:
COLONIC MICROFLORA; COVID-19; INFLAMMATION; MUCINS.
Publication types
Letter
Kommentar
MeSH terms
COVID-19*
Gastrointestinal Microbiome*
Humans
SARS-CoV-2
Grants and funding
R01 HL152756/HL/NHLBI NIH HHS/United States